MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$197.9M
Income tax assets and
liabilities
$119.8M
Stock-based compensation
$57.2M
Depreciation
$7.2M
Inventory
-$4.3M
Non-cash lease expense
$2.7M
Amortization of acquired
intangible assets
$0.1M
Cash flows from
operating activities
$145.8M
Canceled cashflow
$243.4M
Change in cash, cash
equivalents and restricted...
-$446.5M
Canceled cashflow
$145.8M
Sales and maturities
of...
$259.2M
Proceeds from sale of
business
$63.2M
Issuances of common stock
under benefit plans
$23.6M
Accounts receivable
$81.4M
Deferred income taxes
-$61.1M
Other assets and
liabilities, net
$31.4M
Gain on sale of
business, net of...
$28.6M
Changes in fair values of
equity investments
$25.3M
Accounts payable and
accrued liabilities
-$14.3M
Accretion of discount on
available-for-sale debt...
$1.3M
Cash flows from
investing activities
-$506.2M
Canceled cashflow
$322.4M
Cash flows from
financing activities
-$86.1M
Canceled cashflow
$23.6M
Purchases of
available-for-sale debt securities
$819.5M
Capital expenditures
$9.1M
Taxes paid related to
net share...
$55.7M
Repurchases of common stock
$54M
Back
Back
Cash Flow
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)
source: myfinsight.com